Although the number of human infections decreased, human prevalence increased from 4.9% in 1995 to 5.1% in 2004.

The transmembrane glycoprotein mucin 1 (MUC1) is a mucin family member that has different functions in normal and cancer cells. Owing to its structural and biochemical properties, MUC1 can act as a lubricant, moisturizer, and physical barrier in normal cells. However, in cancer cells, MUC1 often undergoes aberrant glycosylation and overexpression. It is involved in cancer invasion, metastasis, angiogenesis, and apoptosis by virtue of its participation in intracellular signaling processes and the regulation of related biomolecules. This review introduces the biological structure and different roles of MUC1 in normal and cancer cells and the regulatory mechanisms governing these roles. It also evaluates current research progress and the clinical applications of MUC1 in cancer therapy based on its characteristics.

Parkinson’s disease is a progressive neurodegenerative disorder resulting from the degeneration of pigmented dopaminergic neurons in the substantia nigra pars compacta. It induces a series of functional modifications in the circuitry of the basal ganglia nuclei and leads to severe motor disturbances. The amino acid glutamate, as an excitatory neurotransmitter, plays a key role in the disruption of normal basal ganglia function regulated through the interaction with its receptor proteins. It has been proven that glutamate receptors participate in the modulation of neuronal excitability, transmitter release, and long-term synaptic plasticity, in addition to being related to the altered neurotransmission in Parkinson’s disease. Therefore, they are considered new targets for improving the therapeutic strategies used to treat Parkinson’s disease. In this review, we discuss the biological characteristics of these receptors and demonstrate the receptor-mediated neuroprotection in Parkinson’s disease. Pharmacological manipulation of these receptors during anti-Parkinsonian processes in both experimental studies and clinical trials are also summarized.

No abstract

During 2020, the COVID-19 pandemic resulted in a widespread lockdown in many cities in China. In this study, we assessed the impact of changes in human activities on air quality during the COVID-19 pandemic by determining the relationships between air quality, traffic volume, and meteorological conditions. The megacities of Wuhan, Beijing, Shanghai, and Guangzhou were selected as the study area, and the variation trends of air pollutants for the period January–May between 2016 and 2020 were analyzed. The passenger volume of public transportation (PVPT) and the passenger volume of taxis (PVT) along with data on precipitation, temperature, relative humidity, wind speed, and boundary layer height were used to identify and quantify the driving force of the air pollution variation. The results showed that the change rates of fine particulate matter (PM 2.5 ), NO 2 , and SO 2 before and during the lockdown in the four megacities ranged from -49.9% to 78.2% (average: -9.4% ± 59.3%), -55.4% to -32.3% (average: -43.0% ± 9.7%), and -21.1% to 11.9% (average: -10.9% ± 15.4%), respectively. The response of NO 2 to the lockdown was the most sensitive, while the response of PM 2.5 was smaller and more delayed. During the lockdown period, haze from uninterrupted industrial emissions and fireworks under the effect of air mass transport from surrounding areas and adverse climate conditions was probably the cause of abnormally high PM 2.5 concentrations in Beijing. In addition, the PVT was the most significant factor for NO 2 , and meteorology had a greater impact on PM 2.5 than NO 2 and SO 2 . There is a need for more national-level policies for limiting firework displays and traffic emissions, as well as further studies on the formation and transmission of secondary air pollutants.